AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,596 Increased By 136 (0.53%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)
World

EU chief defends later vaccine rollout as 'good decision'

  • France's health authority is due later Tuesday to give its verdict on approval of the AstraZeneca vaccine and who it should be used on.
Published February 2, 2021

PARIS: The EU commission chief has defended the slower Covid-19 vaccine rollout in the bloc as a "good decision", saying the European Union would not put the safety of citizens at risk, in an interview published Tuesday.

Ursula von der Leyen's comments in Le Monde French daily come after she was criticised over a far slower vaccine rollout than in the UK and also a botched move to halt the exports of the AstraZeneca vaccine.

"Some countries started to vaccinate a little before Europe, it is true," she said, pointing to emergency procedures used for authorisation.

But she added: "The commission and the member states agreed not to compromise on the safety and effectiveness requirements linked to the authorisation of a vaccine."

With some politicians in Britain claiming the quicker vaccine rollout there had vindicated Brexit, France's Europe Minister Clement Beaune told French radio that the British vaccination rollout was taking "a lot of risks".

"I do not think that our fellow citizens would accept that we take all the risks -- contrary to the opinions of our scientists -- for this vaccination campaign", he told France Inter.

The head start in Britain "has nothing to do with Brexit", he added.

French President Emmanuel Macron said in interviews published Friday that AstraZeneca's coronavirus vaccine -- which is set to be the backbone of the British campaign -- appeared not to be effective for people over 65 years of age.

France's health authority is due later Tuesday to give its verdict on approval of the AstraZeneca vaccine and who it should be used on.

Comments

Comments are closed.